首页> 外文期刊>RSC Advances >Targeted delivery of a novel peptide-docetaxel conjugate to MCF-7 cells through neuropilin-1 receptor: reduced toxicity and enhanced efficacy of docetaxel
【24h】

Targeted delivery of a novel peptide-docetaxel conjugate to MCF-7 cells through neuropilin-1 receptor: reduced toxicity and enhanced efficacy of docetaxel

机译:通过Neuropilin-1受体靶向向MCF-7细胞递送新型肽-多西他赛偶联物:降低多西他赛的毒性并增强其功效

获取原文
获取原文并翻译 | 示例
           

摘要

We have designed a novel peptide-docetaxel conjugate, which delivers docetaxel specifically to cancer cell targeting neuropilin-1 (NRP-1) receptor, thus enhancing its efficacy and acts more aggressively in breast cancer cells.
机译:我们设计了一种新型肽-多西他赛偶联物,可将多西他赛特异地递送至靶向神经纤维蛋白-1(NRP-1)受体的癌细胞,从而增强其功效并在乳腺癌细胞中发挥更大的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号